KEROS THERAPEUTICS, INC. (KROS) Total liabilities 2019–2025
KEROS THERAPEUTICS, INC. (KROS) total liabilities at each fiscal year-end, per SEC filings.
$34.9MFY2025 · since FY2019: $10.5M → $34.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.9M | -21.3% |
| FY2024 | $44.3M | +17.2% |
| FY2023 | $37.8M | +28.8% |
| FY2022 | $29.4M | +143.1% |
| FY2021 | $12.1M | +56.4% |
| FY2020 | $7.7M | -26.2% |
| FY2019 | $10.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice